HeyJaredJournal of Clinical Oncology (JCO) Podcast
The Journal of Clinical Oncology podcast, hosted by Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO's esteemed Journal of Clinical Oncology.
- Indexed episodes, last 90 days
- 5
- Latest publication
- Sep 28, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 16, 2026
Latest episodes
JCO Article Insights: Long-Term Follow-Up of Weekly Cisplatin + RT in Postoperative HNC (opens the original)
Read excerpt
Host Dr. Jake New interviews Dr. Makoto Tahara about the JCO article " Long-Term Follow-Up of JCOG1008, a Randomized Phase II/III Trial of Chemoradiotherapy Comparing 3-Weekly Cisplatin With Weekly Cisplatin in Postoperative Head and Neck Cancer ." They discuss clinical considerations for individualizing treatment schedules and impact of treatment schedule on toxicity and patient quality of life. LINK TO FULL TRANSCRIPT
Dexrazoxane and Long-Term Cardiac Function After Doxorubicin: Insights From COG ALTE11C2 (opens the original)
Read excerpt
How does dexrazoxane affect left ventricular function over time after doxorubicin treatment for childhood cancer? Host Dr. Davide Soldato sits down with Dr. Erin Mobley and Dr. Eric Chow to discuss their article, " Longitudinal Change in Cardiac Function After Doxorubicin and Dexrazoxane: A Report from COG ALTE11C2. " They examine the longitudinal echocardiographic findings, the durability of cardioprotection, and how dexrazoxane exposure might eventually inform cardiomyopathy risk stratificatio
Bladder Adjuvant RadioTherapy (BART) RCT for High Risk MIBC (opens the original)
Read excerpt
Guest Dr. Vedang Murthy and host Davide Soldato discuss JCO article, " Bladder Adjuvant Radiotherapy: Phase III Multicenter Randomized Controlled Trial of Adjuvant Radiotherapy or Observation for Postcystectomy Muscle-Invasive Bladder Cancer " and delve into trial design, results, clinical implications, and future directions in bladder cancer treatment. LINK TO FULL TRANSCRIPT
JCO Article Insights: Duvelisib in Patients with Relapsed or Refractory PTCL (opens the original)
Read excerpt
In this episode of JCO Article Insights, host Ash Gurumurthi summarizes the article " Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma ," by Mehta-Shah and colleagues. LINK TO FULL TRANSCRIPT
Effectiveness of a Virtual Tobacco Treatment for Cancer Patients (opens the original)
Read excerpt
Guests Dr. Elise Park, Dr. Jamie Ostrov and host Dr. Davide Soldato discuss JCO article " Virtual Sustained Tobacco Treatment for Cancer Patients: A Randomized Controlled Trial (ECOG-ACRIN: EAQ171CD) within the NCI Community Oncology Research Program (NCORP) " and their groundbreaking trial on virtual tobacco cessation treatment for cancer patients in community settings. LINK TO FULL TRANSCRIPT
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.
See coverage about Journal of Clinical Oncology (JCO) Podcast